LS Investment Advisors LLC cut its position in shares of Aetna Inc. (NYSE:AET) by 1.1% during the second quarter, Holdings Channel reports. The institutional investor owned 9,270 shares of the company’s stock after selling 105 shares during the period. LS Investment Advisors LLC’s holdings in Aetna were worth $1,132,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of the stock. TIAA CREF Trust Co. FSB MO purchased a new stake in Aetna during the second quarter valued at about $1,463,000. Dowling & Yahnke LLC increased its stake in Aetna by 29.3% in the second quarter. Dowling & Yahnke LLC now owns 4,564 shares of the company’s stock valued at $557,000 after buying an additional 1,035 shares in the last quarter. Evanson Asset Management LLC increased its stake in Aetna by 2.6% in the second quarter. Evanson Asset Management LLC now owns 1,951 shares of the company’s stock valued at $238,000 after buying an additional 50 shares in the last quarter. First Quadrant L P CA increased its stake in Aetna by 261.6% in the second quarter. First Quadrant L P CA now owns 168,353 shares of the company’s stock valued at $20,561,000 after buying an additional 121,800 shares in the last quarter. Finally, Telemus Capital LLC increased its stake in Aetna by 12.5% in the second quarter. Telemus Capital LLC now owns 4,831 shares of the company’s stock valued at $590,000 after buying an additional 537 shares in the last quarter. Institutional investors own 91.95% of the company’s stock.
Shares of Aetna Inc. (NYSE:AET) traded up 0.87% during mid-day trading on Monday, hitting $114.71. The company had a trading volume of 1,703,981 shares. The stock has a market cap of $40.24 billion, a price-to-earnings ratio of 16.81 and a beta of 0.54. The stock’s 50-day moving average is $115.93 and its 200-day moving average is $115.86. Aetna Inc. has a 52-week low of $92.42 and a 52-week high of $123.57.
Aetna (NYSE:AET) last announced its earnings results on Tuesday, August 2nd. The company reported $2.21 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.12 by $0.09. Aetna had a return on equity of 16.44% and a net margin of 3.89%. The business had revenue of $15.95 billion for the quarter, compared to analyst estimates of $15.69 billion. During the same period in the previous year, the company earned $2.05 earnings per share. The company’s revenue for the quarter was up 4.7% compared to the same quarter last year. Equities analysts forecast that Aetna Inc. will post $8.05 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date of this dividend is Tuesday, October 11th. Aetna’s payout ratio is 14.73%.
Several research firms recently issued reports on AET. Zacks Investment Research upgraded Aetna from a “hold” rating to a “buy” rating and set a $128.00 price objective on the stock in a report on Tuesday, October 4th. Evercore ISI began coverage on Aetna in a report on Thursday, September 22nd. They issued a “buy” rating and a $128.00 price objective on the stock. Credit Suisse Group AG reiterated a “hold” rating and issued a $120.00 price objective on shares of Aetna in a report on Tuesday, September 13th. Jefferies Group reiterated a “hold” rating on shares of Aetna in a report on Tuesday, September 6th. Finally, Leerink Swann reiterated an “outperform” rating on shares of Aetna in a report on Wednesday, August 24th. Six analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $132.43.
In other news, Director Jeffrey E. Garten sold 7,100 shares of Aetna stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total transaction of $827,221.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Shawn M. Guertin sold 45,328 shares of Aetna stock in a transaction dated Tuesday, August 23rd. The stock was sold at an average price of $120.21, for a total value of $5,448,878.88. Following the sale, the insider now directly owns 44,883 shares in the company, valued at $5,395,385.43. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.